Steven Campbell, MD, PhD

home / authors / steven-campbell-md-phd

Articles

Dr. Campbell Discusses the Goals of the New RCC Guidelines

Dr. Campbell Discusses the Goals of the New RCC Guidelines

Steven Campbell, MD, PhD
September 8th 2017

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the goals of the newly updated guidelines in renal cell carcinoma.

Read More

Dr. Campbell Discusses Advancements in Kidney Cancer Management

Dr. Campbell Discusses Advancements in Kidney Cancer Management

Steven Campbell, MD, PhD
August 29th 2017

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses recent advancements in the management of kidney cancer.

Read More

Dr. Campbell on the Future of the Management of RCC

Dr. Campbell on the Future of the Management of RCC

Steven Campbell, MD, PhD
August 24th 2017

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the future of the treatment management for patients with renal cell carcinoma (RCC).

Read More

Dr. Campbell on Radical Nephrectomy in RCC

Dr. Campbell on Radical Nephrectomy in RCC

Steven Campbell, MD, PhD
August 22nd 2017

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the role of radical nephrectomy according to the guidelines for patients with renal cell carcinoma (RCC).

Read More

Dr. Campbell on the Guidelines for the Management of Kidney Cancer

Dr. Campbell on the Guidelines for the Management of Kidney Cancer

Steven Campbell, MD, PhD
May 16th 2017

Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses the recent guidelines for the management of patients with kidney cancer.

Read More

Latest Updated Articles

Sarwish Rafiq, PhD
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Jens Hoeppner, FAChirg, FACS, MD
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Published: July 25th 2024 | Updated: July 27th 2024
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Published: July 25th 2024 | Updated: July 27th 2024
Dr Sabari on Barriers to Biomarker Testing in NSCLC
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Treatment Considerations and Patient Selection for CAR T-cell Therapy in R/R ALL
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Expert Insights on ZUMA-3 Data Updates: 4-Year Follow-up and Real World Data